National Health Investors (NYSE:NHI) Releases FY24 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $4.43-$4.44 for the period, compared to the consensus estimate of $4.52. National Health Investors also updated its FY 2024 guidance to 4.430-4.440 EPS.

Analyst Ratings Changes

NHI has been the subject of a number of recent analyst reports. Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price target for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Truist Financial upped their price target on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Finally, Bank of America began coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $73.29.

National Health Investors Stock Up 0.0 %

NHI traded up $0.03 during trading on Wednesday, reaching $76.76. The company had a trading volume of 870,031 shares, compared to its average volume of 246,682. The business’s fifty day moving average price is $80.45 and its 200 day moving average price is $73.14. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27. National Health Investors has a 12 month low of $49.25 and a 12 month high of $86.13. The company has a market cap of $3.34 billion, a P/E ratio of 26.11, a PEG ratio of 5.05 and a beta of 1.05.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Tuesday, August 6th. The real estate investment trust reported $0.81 EPS for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The business had revenue of $84.97 million for the quarter, compared to analyst estimates of $64.95 million. During the same quarter in the prior year, the company earned $1.06 earnings per share. The company’s quarterly revenue was up 9.1% on a year-over-year basis. Equities analysts anticipate that National Health Investors will post 4.48 EPS for the current year.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 annualized dividend and a dividend yield of 4.69%. National Health Investors’s dividend payout ratio is presently 122.45%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.